Harmony Biosciences Holdings Forecast, price target & analysts
Harmony Biosciences Holdings Target price 2025 - Analyst rating & recommendation
Harmony Biosciences Holdings Classifications & Recommendation:
Harmony Biosciences Holdings Price Target
| Target Price | $47.94 |
| Price | $35.29 |
| Potential |
35.85%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Harmony Biosciences Holdings 2026 .
The average Harmony Biosciences Holdings target price is $47.94.
This is
35.85%
register free of charge
$65.10
84.47%
register free of charge
$32.32
8.42%
register free of charge
|
|
| A rating was issued by 17 analysts: 14 Analysts recommend Harmony Biosciences Holdings to buy, 2 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Harmony Biosciences Holdings stock has an average upside potential 2026 of
35.85%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 714.73 | 862.56 |
| 22.80% | 20.68% | |
| EBITDA Margin | 30.04% | 32.28% |
| 19.02% | 7.47% | |
| Net Margin | 20.36% | 21.81% |
| 8.05% | 7.14% |
13 Analysts have issued a sales forecast Harmony Biosciences Holdings 2025 . The average Harmony Biosciences Holdings sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Harmony Biosciences Holdings EBITDA forecast 2025. The average Harmony Biosciences Holdings EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Harmony Biosciences Holdings Analysts have issued a net profit forecast 2025. The average Harmony Biosciences Holdings net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.51 | 3.27 |
| 17.84% | 30.28% | |
| P/E | 10.80 | |
| EV/Sales | 1.77 |
13 Analysts have issued a Harmony Biosciences Holdings forecast for earnings per share. The average Harmony Biosciences Holdings EPS is
This results in the following potential growth metrics and future valuations:
Harmony Biosciences Holdings...
Current Harmony Biosciences Holdings Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Needham |
Locked
➜
Locked
|
Locked | Nov 24 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 24 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 15 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Sep 25 2025 |
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Sep 25 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 25 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Needham:
Locked
➜
Locked
|
Nov 24 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 24 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 15 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Sep 25 2025 |
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Sep 25 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 25 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
